Table 2.
Effect of COVID-19 and the Lockdown on Patients With SNM Devices.
Variables | Canada (Toronto Western Hospital, Toronto, Canada) | Kuwait (Al-Amiri Hospital, Kuwait City, Kuwait) | Saudi Arabia (King Abdulaziz University, Jeddah, Saudi Arabia) | Australia (Austin and Western Health, University of Melbourne, Australia) | Total |
---|---|---|---|---|---|
Treatment of complications during lockdown, if developed | |||||
• None | 49 (61%) | 16 (80%) | 31 (93.9%) | 20 (68.9%) | 116 (71.6%) |
• Phone | 14 (17.5%) | 2 (10%) | 0 (0%) | 8 (27.5%) | 24 (14.8%) |
• Turn off | 5 (6.25%) | 2 (10%) | 2 (6%) | 1 (3.44%) | 10 (7%) |
• ED visit | 12 (15%) | 0 (0%) | 0 (0%) | 0 (0%) | 12 (7%) |
Contact difficulties during lockdown | |||||
• Yes | 7 (8.75%) | 0 (0%) | 3 (9%) | 3 (10%) | 13 (8%) |
• No | 73 (91.25%) | 20 (100%) | 30 (0.9%) | 26 (89.6%) | 149 (91.9%) |
Follow-up preference | |||||
• Attend | 44 (55%) | 13 (65%) | 10 (30%) | 6 (20.6%) | 73 (45%) |
• Phone | 36 (45%) | 7 (35%) | 23 (69.6%) | 23 (79%) | 89 (54.9%) |
Lockdown affecting visit | |||||
• Yes | 27 (33.75%) | 8 (40%) | 32 (96.9%) | 13 (44.8%) | 80 (49%) |
• No | 53 (66.25) | 12 (60%) | 1 (3%) | 16 (55%) | 82 (50.6%) |
Remote programming | |||||
• Yes | 71 (88.75%) | 17 (85%) | 28 (84%) | 29 (100%) | 145 (89.5%) |
• No | 9 (11.25%) | 3 (15%) | 5 (15%) | 0 (0%) | 17 (10%) |